ES474156A1 - Un procedimiento para preparar un compuesto seleccionado delgrupo formado por alquiltiofenoxipropanolamina - Google Patents

Un procedimiento para preparar un compuesto seleccionado delgrupo formado por alquiltiofenoxipropanolamina

Info

Publication number
ES474156A1
ES474156A1 ES474156A ES474156A ES474156A1 ES 474156 A1 ES474156 A1 ES 474156A1 ES 474156 A ES474156 A ES 474156A ES 474156 A ES474156 A ES 474156A ES 474156 A1 ES474156 A1 ES 474156A1
Authority
ES
Spain
Prior art keywords
alkyl
alkylthiophenoxypropanolamines
cycloalkyl
administered
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES474156A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES474156A1 publication Critical patent/ES474156A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/31Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/32Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un procedimiento para preparar un compuesto seleccionado del grupo formado por una alquiltiofenoxipropanolamina de fórmula (* ver fórmula) y sus sales por adición de ácido correspondientes, donde A y B son hidrógeno, R está seleccionado, independientemente, de un grupo formado por hidrógeno y alquilo inferior de 1 a 4 átomos de carbón inclusive; R1 representa un grupo alquilo de 1 a 8 átomos de carbono, inclusive; R2 representa un grupo alquilo de 6 a 12 átomos de carbono, inclusive, o cicloalquilo, teniendo de 5 a 8 átomos de carbono en el anillo y de 2 a 6 átomos de carbono en la cadena alquilénica.
ES474156A 1977-10-11 1978-10-11 Un procedimiento para preparar un compuesto seleccionado delgrupo formado por alquiltiofenoxipropanolamina Expired ES474156A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84116877A 1977-10-11 1977-10-11
US94222278A 1978-09-14 1978-09-14

Publications (1)

Publication Number Publication Date
ES474156A1 true ES474156A1 (es) 1979-10-16

Family

ID=27126241

Family Applications (1)

Application Number Title Priority Date Filing Date
ES474156A Expired ES474156A1 (es) 1977-10-11 1978-10-11 Un procedimiento para preparar un compuesto seleccionado delgrupo formado por alquiltiofenoxipropanolamina

Country Status (21)

Country Link
JP (1) JPS6049188B2 (es)
AR (2) AR224239A1 (es)
AU (1) AU520181B2 (es)
CA (1) CA1116636A (es)
CH (1) CH642349A5 (es)
DE (1) DE2844353C2 (es)
DK (1) DK146005C (es)
ES (1) ES474156A1 (es)
FI (1) FI70883C (es)
FR (1) FR2405932A1 (es)
GB (1) GB2006197B (es)
GR (1) GR73919B (es)
IE (1) IE47449B1 (es)
IL (1) IL55695A (es)
IT (1) IT1109310B (es)
LU (1) LU80345A1 (es)
NL (1) NL7810156A (es)
NO (1) NO146161C (es)
PH (1) PH15824A (es)
SE (1) SE443782B (es)
YU (1) YU41602B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396629A (en) 1980-12-29 1983-08-02 Sterling Drug Inc. Compositions, processes and method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6504268A (es) * 1965-04-03 1966-10-04
DE2551141A1 (de) * 1975-11-14 1977-05-18 Dolorgiet Arzneimittelfabrik Cyclododecylamin-derivate
DE2552266A1 (de) * 1975-11-21 1977-05-26 Dolorgiet Arzneimittelfabrik Cyclohexylamin-derivate

Also Published As

Publication number Publication date
GR73919B (es) 1984-05-22
IL55695A0 (en) 1978-12-17
IE782018L (en) 1979-04-11
GB2006197B (en) 1982-01-27
DE2844353C2 (de) 1984-01-26
GB2006197A (en) 1979-05-02
NO783416L (no) 1979-05-25
FR2405932B1 (es) 1981-03-20
LU80345A1 (fr) 1979-06-15
DE2844353A1 (de) 1979-04-19
IT1109310B (it) 1985-12-16
FI783068A (fi) 1979-04-12
AR223016A1 (es) 1981-07-15
IL55695A (en) 1982-01-31
CH642349A5 (de) 1984-04-13
IT7851437A0 (it) 1978-10-10
PH15824A (en) 1983-04-08
FI70883C (fi) 1986-10-27
CA1116636A (en) 1982-01-19
YU41602B (en) 1987-12-31
AU4039378A (en) 1980-04-17
FI70883B (fi) 1986-07-18
NL7810156A (nl) 1979-04-17
NO146161B (no) 1982-05-03
FR2405932A1 (fr) 1979-05-11
JPS5488232A (en) 1979-07-13
IE47449B1 (en) 1984-03-21
JPS6049188B2 (ja) 1985-10-31
SE7810574L (sv) 1979-04-12
SE443782B (sv) 1986-03-10
DK450978A (da) 1979-04-12
DK146005B (da) 1983-05-16
AU520181B2 (en) 1982-01-21
DK146005C (da) 1989-05-29
NO146161C (no) 1982-08-11
AR224239A1 (es) 1981-11-13
YU235278A (en) 1983-01-21

Similar Documents

Publication Publication Date Title
IE904035A1 (en) Medicaments containing as active substance sulphur-containing carboxylic acids and their use in combating retroviruses
ES2117642T3 (es) Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
KR900700089A (ko) 전신성 피부 투과적 투여를 위한 약학적 조성물
ES471981A1 (es) Un procedimiento para la preparacion de derivados de imida- zoquinazolina
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
PH25508A (en) Substituted quinazoline derivatives for use in gastrointestinal diseases
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
JPS5681546A (en) Secondary amines* their manufacture and medicinal composition containing them
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
KR910005858A (ko) 지방산 요법
DE69008107D1 (de) Zubereitung mit verzögerter Freigabe eines Hydrochlorids eines basischen Arzneistoffs.
ATE8739T1 (de) Pharmazeutische zubereitungen.
ES474156A1 (es) Un procedimiento para preparar un compuesto seleccionado delgrupo formado por alquiltiofenoxipropanolamina
KR890012942A (ko) 5-치환된 오르니틴 유도체
HK175896A (en) Medicament for the treatment of cardiac insufficiency
FR2244481A1 (en) Oral treatment of diabetes - with a complex of glibenclamide and phenformin
Roseman et al. Massive tongue necrosis secondary to temporal arteritis
KR880003973A (ko) 약리적 활성 화합물 및 용도
DE3380294D1 (en) Pharmaceutical compositions in oral dosage form
PH15876A (en) Novel imidazole derivatives and pharmaceutical preparations thereof
JPS56131514A (en) Ketoprofen composition for rectum administration
GB1420976A (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
US3764679A (en) Iodinin as an anti-hypertensive agent
US3806594A (en) Method of reducing involuntary movements associated with cerebral palsy using clorazepate dipotassium
IL88124A0 (en) Pharmaceuticals,phosphorus-containing-2-isoxazolines and isoxazoles contained therein and processes for the preparation of these compounds

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001204